Cushing's syndrome Part 2: Advances in Treatment and in Understanding Complications' Impact

Best Pract Res Clin Endocrinol Metab. 2021 Mar;35(2):101523. doi: 10.1016/j.beem.2021.101523. Epub 2021 Mar 12.

Author

Maria Fleseriu¹

Affiliation

¹ Departments of Endocrinology Diabetes, & Clinical Nutrition and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, OR, USA. Electronic address: fleseriu@ohsu.edu.

PMID: 33757677
DOI: 10.1016/j.beem.2021.101523

No abstract available

Publication types

Editorial

MeSH terms

Cushing Syndrome* / etiology
Cushing Syndrome* / therapy
Humans
Hydrocortisone

Substances

Hydrocortisone